Dermatology News

ORLANDO — In an Healio video exclusive, Jeanine Downie, MD, FAAD, discussed the importance of anti-racism and diversity as well as how to carry out anti-racism as a dermatologist.

Low-dose oral minoxidil was not significantly associated with pericardial effusion among patients with alopecia, according to a study.

Leqselvi demonstrated clinically meaningful improvements long-term in adults with alopecia areata, Sun Pharma announced in a press release.

Histological evaluations showed poly-L-lactic acid injections stimulate skin rejuvenation over time, according to a study.

Deucravacitinib is superior to placebo for improving response across all domains of minimal disease activity criteria in patients with psoriatic arthritis at 16 weeks, according to data published in Rheumatology.

The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.

Roflumilast cream 0.15% showed high efficacy rates among patients aged 6 years and older with mild to moderate atopic dermatitis, according to a study.

ORLANDO — VYC-20L hyaluronic acid injectable filler yielded high satisfaction across skin types for the treatment of temple hollowing, according to a speaker at the American Society for Dermatologic Surgery Annual Meeting.

Nonablative laser therapy plus topical antioxidants significantly decreased post-inflammatory dyschromia associated with acne vulgaris, especially in patients with skin of color, according to a study.

The FDA has extended the target action date of its review of the supplemental new drug application for Vtama cream 1% for the treatment of atopic dermatitis in adults and children aged at least 2 years, Organon announced in a press release.